Skip to content

Study on mechanism and standardization program of acupuncture (composite) anesthesia on pneumonectomy

Study on mechanism and standardization program of acupuncture (composite) anesthesia on pneumonectomy

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001169
Enrollment
Unknown
Registered
2011-01-26
Start date
2008-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The mass chest of qualitative and uncertainty

Interventions

E:TEAS2/100 Hz
B:2Hz
C:2/100Hz
D:100Hz

Sponsors

Peking University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Need lung resection surgery, for the first time receiving acupuncture anesthesia surgery; 2. ASA grade I-II level; 3. Aged 30 to 65 years old, male or female; 4. Hospital laboratory examinations have been perfect, past non-immune system diseases; 5. Have signed informed consent; 6. Hospital ethics committee has approval.

Exclusion criteria

Exclusion criteria: 1. The Meridian line passing through the patient after surgery; 2. Meridian skin infections in patients with locally; 3. Upper or lower extremity nerve injury with patients; 4. Nearly four weeks, patients participated in other clinical trials; 5. The patient can not complete the study plan, including language difficulties, infectious diseases and other medical history.

Design outcomes

Primary

MeasureTime frame
NK;TCM syndromes;Electrolyte;5 - hydroxytryptamine;Blood gas analysis;dynorphin;Light - enkephalin;Ts;Physical type;Glucose;Substance P;IL-6;IL-1;Physiological Index;Bradykinin;Epinephrine;Dose of Fentanyl;Pain threshold /Pain tolerance threshold;Dose of Propofol;

Countries

China

Contacts

Public ContactWeidong Shen
shenweidong1018@hotmail.com+86 13818288281

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026